Showing results (1-10 of 440) with videos related to
Sort By:
Pageof 44
Expert Review of Molecular Diagnostics|March 11, 2010
Multiple cytokine biomarkers in heart failureMaria Vistnes, Geir Christensen, Torbjørn OmlandCurrent Heart Failure Reports|October 5, 2017
Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart FailureAnett H Ottesen, Geir Christensen, Torbjørn Omland, et al.Plos One|March 21, 2014
Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damageHelga Sanner, Thomas Schwartz, Berit Flatø, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 22, 2015
[Diagnostic accuracy for heart failure – data from the Akershus Cardiac Examination 2 Study]Jon Brynildsen, Arne Didrik Høiseth, Ståle Nygård, et al.Regulatory Peptides|July 3, 2013
Effect of short- and long-term physical activities on circulating granin protein levelsHelge Røsjø, Per-Kristian Opstad, Jon Erik Hoff, et al.Rheumatology (Oxford, England)|July 6, 2014
In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunctionThomas Schwartz, Ivar Sjaastad, Berit Flatø, et al.Expert Review of Molecular Diagnostics|March 28, 2008
B-type natriuretic peptides: prognostic markers in stable coronary artery diseaseTorbjørn OmlandCritical Care Medicine|February 15, 2008
Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failureTorbjørn OmlandScandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemiaTorbjørn OmlandBiomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 13, 2016
The influence of heart failure co-morbidity on high-sensitivity troponin T levels in COPD exacerbation in a prospective cohort study: data from the Akershus cardiac examination (ACE) 2 studyArne Didrik Høiseth, Jon Brynildsen, Tor-Arne Hagve, et al.Pageof 44